Uncategorised - European Medical Journal

Parkinson’s Symptoms Improved in TEMPO-2 Trial: AAN 2025

New results from the Phase III TEMPO-2 trial, presented at the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego, indicate that flexible-dose tavapadon significantly improved motor symptoms and daily functioning in adults with early Parkinson’s disease (PD), compared with placebo.

EBMT Interview: Chiara Nozzoli

In this interview, Chiara Nozzoli, speaks on her career journey and her work in haematopoietic stem cell transplantation, particularly in…

Interview: Lindsay Ackerman

It’s phenomenally satisfying to see the investments that the industry has made in trying to continue to move the needle forward in the…

British governmental buildings

UK government unveils Health Data Research Service

The UK government has announced a significant new initiative to accelerate drug discovery and improve patient care in the country.

Metastasis Clearance Linked to Improved Outcomes in mHSPC

The findings revealed that total radiographic disappearance of metastases occurred in 15% of patients.

Gene Therapy Shows Promise for Recurrent Respiratory Papillomatosis

A novel therapeutic vaccine, PRGN-2012, has shown promising results in treating recurrent respiratory papillomatosis.

AI-Enhanced Ultrasound Scans Improve Efficiency and Reduce Sonographer Stress

AI can enhance the efficiency and accuracy of fetal anomaly ultrasound scans, reducing the workload on sonographers while maintaining high diagnostic performance.

ADHD Increases Dementia Risk due to Brain Iron and Axonal Damage

ADHD may increase risk of dementia due to elevated brain iron and neuroaxonal damage in adults.

Dennise Broderick Galen Pharma

Galen’s Dr Dennise Broderick on why kindness isn't a weakness in business

Dr Dennise Broderick, President and Managing Director, Galen Pharma joins the GOLD podcast to discuss her life-long ambition to be a leader and how she approaches hard decisions in business.

Study Shows Mobile Health Intervention Feasible for Type 2 Diabetes Patients

A study has demonstrated the feasibility of a mobile health-supported home-delivered physical activity programme for individuals recently diagnosed with Type 2 diabetes.